Inventor
CHOI SOONGYU
US37 patents
⚠️ This page may combine multiple inventors who share the name “CHOI SOONGYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
13 patentsUS9371336B2Jun 21, 2016
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC36 citations94
US9879007B2Jan 30, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC18 citations93
US9617268B2Apr 11, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC32 citations93
US9586955B2Mar 7, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC22 citations93
US7767689B2Aug 3, 2010
Carboline derivatives useful in the treatment of cancer
PTC THERAPEUTICS INC40 citations92
US7601840B2Oct 13, 2009
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC39 citations92
US8372860B2Feb 12, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US8367694B2Feb 5, 2013
Carboline derivatives useful in the inhibition of angiogenesis
PTC THERAPEUTICS INC12 citations83
US9271960B2Mar 1, 2016
Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
PTC THERAPEUTICS INC4 citations71
US11753407B2Sep 12, 2023
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations61
US10584115B2Mar 10, 2020
Substituted pyridine and pyrazine BMI-1 inhibitors
PTC THERAPEUTICS INC1 citations61
US10851101B2Dec 1, 2020
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
USRE47689ENov 5, 2019
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
GREEN CROSS CORP
6 patentsUS9340521B2May 17, 2016
Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
GREEN CROSS CORP6 citations71
US10239873B2Mar 26, 2019
7-azaindole or 4,7-diazaindole derivatives as IKKϵ epsilon and TBK1 inhibitor and pharmaceutical composition comprising same
GREEN CROSS CORP4 citations70
US10294207B2May 21, 2019
Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same
GREEN CROSS CORP2 citations59
US9371303B2Jun 21, 2016
Diphenylmethane derivatives as SGLT2 inhibitors
GREEN CROSS CORP0 citations50
US9988372B2Jun 5, 2018
Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same
GREEN CROSS CORP0 citations48
US9856216B2Jan 2, 2018
Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same
GREEN CROSS CORP0 citations39
BAYER PHARMACEUTICALS CORP
5 patentsUS6960601B2Nov 1, 2005
Preparation and use of imidazole derivatives for treatment of obesity
BAYER PHARMACEUTICALS CORP26 citations91
US6784167B2Aug 31, 2004
17-beta-hydroxysteroid dehydrogenase-II inhibitors
BAYER PHARMACEUTICALS CORP35 citations89
US7592361B2Sep 22, 2009
Indole acetic acid derivatives and their use as pharmaceutical agents
BAYER PHARMACEUTICALS CORP0 citations51
US7714004B2May 11, 2010
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
BAYER PHARMACEUTICALS CORP0 citations49
US7071207B2Jul 4, 2006
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
BAYER PHARMACEUTICALS CORP0 citations40